 So they're going to be reporting, and I'm really interested specifically, they are a supplier in the biopharma industry, and we have had an absolute, you know, a huge amount of increase in spending in research, particularly the GLP-1 drugs and similar things in that area. So I'm really interested to see what their revenue base looks like.